389 related articles for article (PubMed ID: 12321195)
1. Characteristics of contraceptive acceptors in Luanda, Angola.
Carvalho A; Laudari C; Marini M; Faundes A
Afr J Fertil Sexual Reprod Heal; 1996 Dec; 1(2):109-14. PubMed ID: 12321195
[TBL] [Abstract][Full Text] [Related]
2. The relevance of ethnic monitoring in the experience of Haringey Healthcare NHS trust community family planning clinics.
Christopher E
Br J Fam Plann; 1999 Jan; 24(4):123-7. PubMed ID: 10023096
[TBL] [Abstract][Full Text] [Related]
3. Vanguard contraceptive users subject of Senegal research.
Netw Res Triangle Park N C; 1985; 6(2):5-7. PubMed ID: 12266648
[TBL] [Abstract][Full Text] [Related]
4. Socio-demographic characteristics of family planning clients and their possible influence on contraception in Malawi.
Lema VM; Mtimavalye LA; Msiska FS
East Afr Med J; 1998 Jan; 75(1):41-6. PubMed ID: 9604534
[TBL] [Abstract][Full Text] [Related]
5. The 1974 National Acceptors Survey.
Laing J; Phillips J; Zablan Z; Llorente R; Cabigon J
Popul Forum; 1976; 2(7):2-7. PubMed ID: 12277595
[TBL] [Abstract][Full Text] [Related]
6. Depo-Provera: costs eat up clinic contraceptive budgets.
Contracept Technol Update; 1999 Jan; 20(1):1-3. PubMed ID: 12349019
[TBL] [Abstract][Full Text] [Related]
7. Utilisation of family planning services at the teaching hospital in Blantyre, Malawi.
Lema VM; Mtimavalye LA; Gondwe EE
East Afr Med J; 1994 Nov; 71(11):703-11. PubMed ID: 7859653
[TBL] [Abstract][Full Text] [Related]
8. Survey report: Senegal.
Kent MM
Popul Today; 1988 Feb; 16(2):5. PubMed ID: 12341736
[TBL] [Abstract][Full Text] [Related]
9. [The Tunisian experience in family planning: recorded results].
Bel Hadj Ali BE; Salablab A; Bouraoui A
Al Usrah Wa Al Umran Al Bashari; 1988 Nov; (Spec No):50-66. PubMed ID: 12179483
[TBL] [Abstract][Full Text] [Related]
10. Uganda women shy away from the pill.
Sekatawa EK
Afr Women Health; 1993; 1():27-30. PubMed ID: 12287500
[TBL] [Abstract][Full Text] [Related]
11. The contraceptive practices of women seeking termination of pregnancy in an Auckland clinic.
Young LK; Farquhar CM; McCowan LM; Roberts HE; Taylor J
N Z Med J; 1994 May; 107(978):189-92. PubMed ID: 8196861
[TBL] [Abstract][Full Text] [Related]
12. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
[TBL] [Abstract][Full Text] [Related]
13. Adolescent knowledge and use of injectable contraceptives in developing countries.
Singh S
J Adolesc Health; 1995 May; 16(5):396-404. PubMed ID: 7662691
[TBL] [Abstract][Full Text] [Related]
14. Survey report: Jordan.
Roudi N
Popul Today; 1991 Dec; 19(12):4. PubMed ID: 12317100
[TBL] [Abstract][Full Text] [Related]
15. Depo-provera: clinical evaluation.
Mukherjea M
Contracept Deliv Syst; 1981 Jul; 2(3):259-69. PubMed ID: 12278913
[TBL] [Abstract][Full Text] [Related]
16. Introducing more contraceptive methods in Jordan.
Gallagher M
AVSC News; 1998; 36(1):3, 8. PubMed ID: 12321883
[TBL] [Abstract][Full Text] [Related]
17. [Contraception in Mauritius (Author's transl)].
Elia D
Contracept Fertil Sex (Paris); 1980 Jul; 8(7):603-5. PubMed ID: 12262566
[TBL] [Abstract][Full Text] [Related]
18. [Prospects for family planning in 1991 in Tunisia].
Bchir M; Kilani T; Alaoui T; Zmerli S
Al Usrah Wa Al Umran Al Bashari; 1988 Nov; Spec No():35-49. PubMed ID: 12179484
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the 1995 and 1989 Kenya Situation Analysis Study findings.
Miller R; Miller K; Ndhlovu L; Solo J; Achola O
Afr J Fertil Sexual Reprod Heal; 1996 Dec; 1(2):162-8. PubMed ID: 12321199
[TBL] [Abstract][Full Text] [Related]
20. What is breast cancer risk with Depo-Provera?
Contracept Technol Update; 1992 Jan; 13(1):15-6. PubMed ID: 12343459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
